Should You Invest In GW Pharmaceuticals Plc?

Get the facts about trading GW Pharmaceuticals Plc before you start. Discuss investment strategies, review market research, and get real-time updates

621,176 GW Pharmaceuticals Plc positions opened on eToro

Buy GWPH
Sell GWPH
GWPHGW Pharmaceuticals Plc
219.090.03 ( 0.01%)
AAPL
AAPLApple
124.84 (-1.12%)
buy
GOOG
GOOGAlphabet
2304.83 (-0.77%)
buy
FB
FBFacebook
309.90 (-1.74%)
buy
MSFT
MSFTMicrosoft
242.99 (-0.86%)
buy
TWTR
TWTRTwitter
53.19 (1.12%)
buy

GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, UK. It is a biopharmaceutical company, which is currently focused on developing and marketing cannabinoid-based medicines for a range of disease areas. Key products include Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD), and Sativex (nabiximols), which is used for the treatment of spasticity due to multiple sclerosis (MS). The Company operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. Follow the GWPH instrument to learn all about the latest news and developments.

Buy GWPH Now
Sell GWPH Now

Historical Price Charts

Discover the eToro Advantage

Use eToro's advanced risk management tools to protect your positions. Enjoy hassle-free deposits and withdrawals, instant execution of trades and a free $100,000 demo account to practice your strategy.

Volatility means opportunity! Watch price changes reflect directly onto your portfolio

Start trading within minutes - no physical purcase delays

Benefit from falling prices as well as rising prices. Buy or sell instantly

关注我们

微信公众号: e投睿eToro

eToro (Europe) Ltd., a Financial Services Company authorised and regulated by the Cyprus Securities Exchange Commission (CySEC) under the license # 109/10.

eToro AUS Capital Pty Ltd. is authorised by the Australian Securities and Investments Commission (ASIC) to provide financial services under Australian Financial Services Licensce 491139.

eToro (UK) Ltd, a Financial Services Company Authorised and regulated by the Financial Conduct Authority (FCA) under the license FRN 583263.

Past performance is not an indication of future results.
General Risk Disclosure | Terms & Conditions

CFDs are leveraged products. Trading in CFDs related to foreign exchange, commodities,indices and other underlying variables, carries a high level of risk and can result in the loss of all of your investment. As such, CFDs may not be suitable for all investors. You should not invest money that you cannot afford to lose. Before deciding to trade, you should become aware of all the risks associated with CFD trading, and seek advice from an independent and suitably licensed financial advisor. Under no circumstances shall we have any liability to any person or entity for (a) any loss or damage in whole or part caused by, resulting from, or relating to any transactions related to CFDs or (b) any direct, indirect, special, consequential or incidental damages whatsoever. Trading with eToro by following and/or copying or replicating the trades of other traders involves a high level of risks, even when following and/or copying or replicating the top-performing traders. Such risks includes the risk that you may be following/copying the trading decisions of possibly inexperienced/unprofessional traders and the overall risk associated in CFD trading or traders whose ultimate purpose or intention, or financial status may differ from yours. Past performance of an eToro Community Member is not a reliable indicator of his future performance. Content on eToro's social trading platform is generated by members of its community and does not contain advice or recommendations by or on behalf of eToro - Your Social Investment Network.

Start Trading
got it